← Back to Search

Light Therapy

Light therapy for Major Depression

N/A

Waitlist Available

Led By Raymond W Lam, MD

Research Sponsored by University of British Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4, 8, 12 weeks

Awards & highlights

Study Summary

This trial will help determine what makes people more or less likely to stick to a light therapy regimen for depression.

Eligible Conditions

Major Depression

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4, 8, 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4, 8, 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4, 8, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence

Secondary outcome measures

Change in clinician-rated depressive symptoms

Change in patient-rated depressive symptoms

Discontinuation symptoms

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Light therapyExperimental Treatment1 Intervention

Daily exposure on weekdays to a standard light device (e.g., fluorescent light box such as the Carex Day-Light Classic, emitting 4000 Kelvin white light rated at 10,000 lux at 14 inches from screen to cornea, with an ultraviolet filter) for 30 minutes as soon as possible after awakening, preferably between 7:00-8:00 am. Participants will also taper and discontinue their antidepressant medication.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Light therapy

2004

N/A

~250

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Michael Smith Foundation for Health ResearchOTHER

19 Previous Clinical Trials

6,089 Total Patients Enrolled

University of British ColumbiaLead Sponsor

1,415 Previous Clinical Trials

2,467,006 Total Patients Enrolled

Raymond W Lam, MDPrincipal InvestigatorUniversity of British Columbia

2 Previous Clinical Trials

160 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any unfilled positions to participate in the clinical trial?

"Affirmative! Clinicaltrials.gov provides evidence that this medical trial is presently looking for participants and was initially posted on August 1st 2021. Ten patients are needed to be recruited from a single site, with the information last updated on September 28th 2021."

Answered by AI

Who has the opportunity to take part in this experiment?

"This clinical experiment is recruiting 10 individuals, aged 19 to 65, who are diagnosed with involutional psychosis. In addition to the age criteria, participants must have been on antidepressants for 6 months or less; express a desire to discontinue medication due to side effects/other reasons; and score ≤10 on the MADRS scale."

Answered by AI

Can persons aged 75 or younger participate in this experiment?

"Individuals that are between 19 and 65 years old may take part in this medical research project."

Answered by AI

How many participants has the experiment recruited thus far?

"Affirmative. Data available on clinicaltrials.gov confirms that this medical experiment, which was first published on August 1st 2021, is actively enrolling volunteers. 10 people are required to be recruited from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Adherence to Light Therapy

Raymond Lam 2021. "Feasibility of Adherence to Light Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04944758.